AMYLOMICS
AmylolEnzymes Captured by Targeted Metagenomics
| Coordinatore | MATIS OHF
Organization address
address: VINLANDSLEID 12 contact info |
| Nazionalità Coordinatore | Iceland [IS] |
| Totale costo | 3˙550˙541 € |
| EC contributo | 2˙448˙158 € |
| Programma | FP7-KBBE
Specific Programme "Cooperation": Food, Agriculture and Biotechnology |
| Code Call | FP7-KBBE-2010-4 |
| Funding Scheme | CP-FP |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-03-01 - 2014-02-28 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
MATIS OHF
Organization address
address: VINLANDSLEID 12 contact info |
IS (REYKJAVIK) | coordinator | 638˙546.00 |
| 2 |
RIJKSUNIVERSITEIT GRONINGEN
Organization address
address: Broerstraat 5 contact info |
NL (GRONINGEN) | participant | 415˙643.00 |
| 3 |
UNIVERSITAET STUTTGART
Organization address
address: Keplerstrasse 7 contact info |
DE (STUTTGART) | participant | 371˙160.00 |
| 4 |
LUNDS UNIVERSITET
Organization address
address: Paradisgatan 5c contact info |
SE (LUND) | participant | 370˙564.00 |
| 5 |
SEMGEN DOO ZA RACUNALNO PROGRAMIRANJE I SAVJETOVANJE
Organization address
address: LANISTE 5D contact info |
HR (ZAGREB) | participant | 208˙351.00 |
| 6 |
ROQUETTE FRERES SA
Organization address
address: RUE DE LA HAUTE LOGE contact info |
FR (LESTREM) | participant | 149˙214.00 |
| 7 |
Ingenza Limited
Organization address
address: Wallace Building, Roslin BioCentre contact info |
UK (Roslin) | participant | 122˙418.00 |
| 8 |
PROKAZYME EHF
Organization address
address: VINLANDSLEIO 14 contact info |
IS (REYKJAVIK) | participant | 110˙902.00 |
| 9 |
ROCHE NIMBLEGEN INC
Organization address
address: SOUTH ROSA ROAD 504 contact info |
US (MADISON WI) | participant | 61˙360.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The aim of the AMYLOMICS project is to develop novel, robust enzymes for the starch and carbohydrate industries. The novel enzymes should enable the formation of new primary products, such as oligosaccharides of defined sizes, composition and degree of branching, new types of linkages, cyclic or more complex polysaccharides and an increased digestive resistance, as well as secondary sugar derivatives such as substituted starches, rare sugars or novel isomers.
Fundamental to the success of the project will be the development of an efficient metagenomic platform technology for enzyme screening based on massive parallel 454 sequencing and microarray sequence capture. This platform will enable “genome walking” of complex metagenomic DNA and greatly facilitate the access to the largely unexplored wealth of genes in the environment.
The starch industry is the most developed sector of the polysaccharide industry and European companies play a leading role in the world market. The industry is in a constant need for a range of robust enzymes that can be used for the synthesis, fractionation and/or modification of carbohydrates. It actively searches for sustainable and more economical alternatives to existing techniques, both for the production of novel higher value products and for the improvement of older processes. The metagenomic mining platform developed in the project is expected to provide a large number of robust thermophilic starch and carbohydrate modifying enzymes and lead to new and improved biocatalytic process technologies. Lead users of the project’s results will be companies like the project partners Roquette Frères, a world leader in starch processing, Roche Molecular Systems, a leading providers of new tools, technologies and services in the genomic industry, and SME companies like Prokazyme who through the improvement of sequence based metagenomic bioprospecting platform can expand their product range of speciality products.'